Background: Most early-onset forms of Alzheimer's disease are due to missense mutations located on two homologous proteins named presenilin 1 and 2 (PS1 and PS2). Several lines of evidence indicate that PS 1 and PS2
Introduction
Familial forms of Alzheimer's disease are due to inherited mutations on genes, the loci of which have been identified on chromosomes 21, 14 , and 1 (for review see ref. 1 ). The gene products of chromosomes 1 and 14 have been shown to be responsible for most early-onset forms of Alzhei-mer's disease and have been identified as presenilins 2 and 1 (PS2 and PS1), respectively (2-4). PS1 and PS2 are highly homologous transmembrane proteins (5, 6 ) located mainly in the endoplasmic reticulum (7) (8) (9) (10) (11) and Golgi apparatus (10, 11) . These proteins undergo various posttranscriptional modifications (for reviews see refs. 12, 13) and are particularly susceptible to endoproteolytic cleavages giving rise to N-terminal (NTF) and C-terminal (CTF) fragments (14) (15) (16) (17) . This cleavage by an as-yet unknown protease seems to be a major event since intact PS holoproteins are poorly detectable in the brain of transgenic mice and affected patients and the two proteolytic fragments appear to accumulate with a 1 / 1 stochiometry (15) . Interestingly, NTF anf CTF undergo phosphorylation events (9, 18) , behave as targets of caspase-mediated proteolysis (19) (20) (21) , and can physically interact (12, 13) . Whether these post-transcriptional events reflect regulatory mechanisms aimed at modulating putative NTF and CTF biological activity remains to be established.
We have examined whether the expression of CTF-PS1/PS2 modulates the processing of ,BAPP in HEK293 cells. We show that both CTF-PSI and CTF-PS2 expression leads to increased secretion of AP3 and APPa. Furthermore, we establish that both PS maturated fragments are catabolized by the proteasome. Accordingly, two proteasome inhibitors drastically potentiate the CTF-mediated increase in the recovery of both ,3APP maturation products. Altogether, our data indicate that CTF-PS1 and CTF-PS2 are biologically active and in particular, control ,APP maturation. This function appears to be directly modulated by the proteolytic catabolism elicited by the proteasome.
Materials and Methods

Design of CTF-PS1 and CTF-PS2 cDNAs
The cDNA encoding CTF-PS1 (ct-i) was engineered by introducing the Kosak sequence of PS1 upstream of the ATG codon encoding the PSI methionine in position 292 (oligo: 5'-CAT-AGG-ATC-CGT-TGC -TCC -AAT-GGT-GTG-GTT-GGT-GAA-TAT-GGC-AGA-A-3' ). An additional BamHl restriction site was also added, adjacent to the Kosak sequence for further subcloning of the construction in pcDNA3 (ct-i). The cDNA construction coding for CTF-PS2 (ct-2) was engineered similarly, with the Kozak sequence of PS2 upstream of the ATG codon encoding the methionine in position 298 and an additional Kpn restriction site adjacent to the Kozak sequence (oligo: 5' -ATC-TGG-TAC-CGG-CAG-GGC -TAT-GGT-GTG-GAC-GGT-TGG-CAT-GGC-GAA-G-3'). (25) . Samples were centrifuged, and the pellets were washed three times with RIPA 1X containing NaCl (350 mM), rinsed with TBS buffer, then resuspended in the loading buffer, electrophoresed on 8% SDS-PAGE (APPa) or Tris-tricine gels (Af3), and Western blotted for 1-3 hr. Nitrocellulose sheets were capped with skim milk (5% in TBS buffer) and exposed overnight to a 200-fold dilution of mAblOD5C (APPa) or 1 ,g/ml of W02 (A,3) antibodies. The nitrocellulose sheets were rinsed with TBS buffer then incubated with adequate anti-IgGs, revealed, and quantified as previously described (25) .
Western Blot Analysis of ,BAPP and CTFs
Immunoreactivity
Stably transfected cells were treated as above then lysed in 50 mM Tris-HCl, pH 7.5, containing 150 mM of NaCl and protease inhibitors (5 mM EDTA, 1 mM leupeptin, 1 ,uM pepstatin and 1 mM AEBSF). Analysis for ,3APP and CTF-PS1/ CTF-PS2 contents was performed by means of BR188 antibody or aLoopPSl/PS2 as described previously (26) . (8) 11 (6) (8) (Fig. 1 C) . Both CTF-expressing clones secreted higher amounts of AP3 than Mock/m control cells (Fig. 1D) . Transient transfection of Mock, CPS 1, and CPS2 clones with wt-4APP751 cDNA (wt) led to increased A,8 secretion, the production of which was higher in CPS 1 and CPS2 than in Mock-transfected cells (Fig. 1 C, D) . We examined the putative influence of CTF-PSI and CTF-PS2 expression on the secretion of the a-secretase-derived physiological product of ,3APP maturation, APPa. Two independent clones of CPS 1 and CPS2 produced higher amounts of APPa than Mock-transfected cells ( Fig. 2A, B) . Transient transfection of Mock, CPS1, and CPS2 ( Fig. 2C ) with empty pcDNA3 (m) or wt-f3APP751 cDNA (wt) confirmed that the CTF-PSs-expressing cells secrete more APPa than the Mock-transfected cells (Fig. 2D) .
The effect of the proteasome inhibitor Z-IE(Ot-Bu)A-Leucinal on CTF-PS1 and CTF-PS2 immunoreactivity in stable transfectants was also examined. Figure 3 indicates that immunoreactivity of both CTF-PS 1 (Fig. 3A) and CTF-PS2 (Fig. 3B) is highly enhanced by Z-IE(Ot-Bu)ALeucinal. The involvement of the proteasome in CTF degradation is further demonstrated by the enhancement of CTF immunoreactivity upon treatment with lactacystin, a very potent and selective proteasome blocker (Fig. 3C) . It should be noted that a smir of high-molecular-weight proteins is detectable upon proteasome inhibi- were lysed, then immunoreactivity of CTF-PS was revealed with aPSILoop and aPS2Loop antibodies as described in Materials and Methods.
tion (see Fig. 3B ), which could reflect protection of ubiquitinated forms of CTF as was shown for presenilin 1 (23) and presenilin 2 (29) . Other protease blockers unable to inhibit the proteasome activity do not modify CTF-PS1/2 recovery (Fig. 3C) . Thus, Z-L-Leucinal (calpain and cathepsin B inhibitor), E64 (thiol and serine protease inhibitor), AEBSF (serine protease inhibitor), phosphoramidon (endopeptidase 3.4.24.11 inhibitor), and pepstatin (acid protease inhibitor) do not protect CTF-PS 1 and CTF-PS2 from degradation in HEK293 cells (Fig. 3C) .
If CTF-PS 1/2 degradation by the proteasome is physiologically relevant, one would expect to potentiate their stimulatory effect on A,B and APPa secretion upon proteasome inhibition. Z-IE(Ot-Bu)A-Leucinal augments the APPa secretion triggered by CPS1 and CPS2 transfectants (Fig. 4A, B) . This inhibitor also potentiates the secretion of AP3 by wt-,3APP751 -expressing transfectants (WT) transiently transfected with ct-I and ct-2 constructions (Fig. 4C, D) . Therefore, it can be concluded that inhibition of the proteasome potentiates the effect of CTF-PS 1 and CTF-PS2 on both a-and 1/,y-secretase-derived products of ,3APP maturation in HEK293 cells.
Discussion
We have previously established that the proteasome contributes to the maturation of endogenous ,3APP in human cells. Thus, proteasome inhibitors increase the recovery of both AP3 and APPa in naive HEK293 cells (22) . This led us to hypothetize that a cellular intermediate located upstream to the a-and 3/-y-secretases cleavages and behaving as substrate of the proteasome plays an important role in IAPP maturation. The search for such an effector led us to suggest that PS1 and PS2 could fulfill such a role. First, we showed that overexpression of PSI (26) and PS2 (24) elicit an increased secretion of both AB and APPa. Second, we demonstrated that PSI and and APPa secretion by stably transfected HEK293 expressing CTF-PS1 and CTF-PS2. Stable transfectants overexpressing CTF-PS1 (CPS1-6 and CPS1-17) and CTF-PS2 (CPS2-1 and CPS2-8) were grown as described in Materials and Methods then APPa secretion was initiated in the absence (-) or presence (+) of Z-IE(Ot-Bu)A-leucinal. APPa was immunoprecipitated after 5 hr by means of 207 antibody and revealed with mAblOD5C (A). Stable transfectants overexpressing wt-f3APP75 1 (WT) were PS2 behave as excellent substrates of the proteasome (23, 24) , which is in agreement with other studies (29, 30) . Third, we established that the proteasome inhibitors exacerbate the PS1/PS2-induced increased recovery of both f3APP maturation products (23, 24) . Interestingly, proteasome inhibitors also exacerbate the phenotypic alterations of ,BAPP maturation triggered by FAD-linked PS mutations (23, 24) . Therefore, we suggested that PS1 and PS2 control P3APP maturation upstream to secretases, and that this function is directly modulated by catabolic events triggered by the proteasome.
Presenilins undergo several post-transcriptional modifications that include phosphorylation and proteolytic cleavages by unknown proteases as well as by caspase 3 (12, 13 It has been documented that CTF-PS1 and its N-terminal counterpart (NTF) interact to form stable heterodimers with a 1:1 stochiometry (15) . If this also holds for the CTF-PS2 and NTF-PS2 derivatives, it is questionable whether the phenotype observed when overexpressing CTF-PS2 mimicks the physiological function of endogenously produced CTF-PS2, since the 1:1 stochiometry of endogenous fragments theoretically preclude CTFs from interacting with endogenous NTFs-this fragment would not be available as a free entity. However, it should be noted that several studies have indicated that transient or stable transfection of PS2 led to apoptosis and that transfection of CTF-PS2 cDNA antagonized this effect in various cell systems, suggesting that overexpression of this fragment elicits a physiologically relevant phenotype (32) .
Interestingly, Tomita and colleagues also recently examined the effect of overexpression of CTF-PS2 in stably transfected cells and concluded that this did not affect ,BAPP maturation (33) . These discrepancies with our present work can likely be explained by several factors. The CTF constructions used in the Tomita study had different N-termini from ours. Also, the effect of CTF expression was monitored on x-40/42 species that likely include a major contribution of N-terminally truncated fragments derived from either pathogenic or also physiologic cleavages (33) , whereas our antibodies were able to monitor total but genuine A,B. Part of the data in Tomita's study concerns the effect of CTF on x-40/42 fragments derived from the C 100 ,BAPP construction, the processing/routing of which could be different from full-length I3APP. Finally, it can be noted that the respective cells systems are totally distinct [COS and N2a (33) versus HEK293 cells (present study)].
Our study documents the fact that CTF-PS1 and CTF-PS2 exhibit biological activity and particularly, control P3APP maturation. This does not preclude the possibility that intact remaining PS holoproteins also play a role in ,BAPP processing. The site of action of CTF is likely located upstream to a-and 3/,y-secretases cell compartments since both Af3 and APPa secretions are similarly affected. This is in agreement with the fact that PS and their fragments have been mainly identified in the endoplasmic reticulum (7-1 1). It is interesting to emphasize that such a compartment has been shown to be accessible to the proteasome, therefore reinforcing the likelihood of involvement of the proteasome in the modulation of f3APP maturation through control of the intracellular concentration of CTF-PS1 and CTF-PS2.
